Abstract:Objective To analyze the correlation between protein expression of X -ray repair cross complementing group 1 (XRCC1)and excision repair cross complementing 1 (ERCC1)with efficacy of concurrent radiochemotherapy(CRT)and the prognosis of patients with esophageal aquamous cell carcinoma(ESCC).Methods Immunohistochemical SP method was used to measure the protein expression of XRCC1 and ERCC in 98 ESCC tissue samples before CRT.The Kaplan -Meier method was used for survival analysis,and the log rank test was used for analyzing the survival difference between negative and positive sam-ples.The Cox model was used for multivariate prognostic analysis.Results XRCC1 and ERCC1 protein were mainly expressed in the nucleus in ESCC.There was no correlation between them (r =-0.024,P =0.811 ).The positive expression rate of XRCC1 protein in ESCC tissues and normal esophageal tissues were 57.1%(56 /98)and 13.3%(4 /30)respectively (χ2 =17.702,P =0.000).The positive expression rate of ERCC1 protein in ESCC tissues and normal esophageal tissues were 36.7%(36 /98)and 10%(3 /30)respectively(χ2 =7.749,P =0.006).The level of ERCC1 was not correlated with clinical pathologic characteristics (P >0.05).The positive expression rate of ERCC1 protein in negative lymphnode group was 44.9% (31 /69), higher than 17.2% (5 /29)in positive lymphnode group,and the difference was statistically significant (χ2 =8.183,P =0.004).The patients with positive XRCC1 expression and negative XRCC1 expression had similar short -term responses(χ2 =0.894,P =0.344)as well as similar survival rates(χ2 =0.266,P =0.606).The RR of ERCC1 negative expression group was 90.3%(56 /62),and the RR of ERCC1 positive expression group was 80.5%(29 /36),but there was no statistically significant difference (χ2 =1.888,P =0.169).The median overall survival periods of ERCC1 negative expression group was 39 months (95% CI:29.313 ~48.687 months),higher than 25 months (95% CI:18.559 ~31.441 months)in positive expression group, the difference was statistically significant (χ2 =10.174,P =0.001).In multivariate analysis,the expression of ERCC1 was closely correlated with overall survival and was the independent prognostic factor (P =0.010,95% CI:1.180 ~3.450).Conclusion ERCC1 expression was associated with the efficacy of CRT,and the patients with ERCC1 positive expression had poor prognosis.

Relationship Between Survivin Expression and Chemoradiotherapy Response in Esophageal Squamous Cell Carcinoma

Expression of Survivin and Its Correlation with Expression of Bcl-2 and P53 in Colorectal Adenocarcinoma

THE EXPRESSION AND CLINICAL SIGNIFICANCE OF SURVIVIN AND VASCULAR ENDOTHELIAL GROWTH FACTOR IN ESOPHAGEAL CANCER

Expressions of HIF-1α and Survivin in Esophageal Squamous Cell Carcinoma and Their Effect on Prognosis after Radiotherapy

Clinicopathological And Prognostic Significance Of Survivin Over-Expression In Patients With Esophageal Squamous Cell Carcinoma: A Meta-Analysis

Analysis of correlation between protein expression of XRCC1 and ERCC1 with efficacy of concurrent radiochemotherapy and the prognosis of patients with esophageal aquamous cell carcinoma

Oct4 Positively Regulates Survivin Expression To Promote Cancer Cell Proliferation And Leads To Poor Prognosis In Esophageal Squamous Cell Carcinoma

Expression and Clinical Significance of HIF-1α, VEGF and Survivin in Esophageal Squamous Cell Carcinoma

Association of decreased expression of long non-coding RNA LOC285194 with chemoradiotherapy resistance and poor prognosis in esophageal squamous cell carcinoma

The clinical significance of ERCC1 in predicting the response to platinum-based chemoradiotherapy and prognosis of esophageal squamous cell carcinoma

Prognostic factors of metastatic or recurrent esophageal squamous cell carcinoma in patients receiving three-drug combination chemotherapy.

Expression and Clinical Significance of HSP90α and Survivin in Esophageal Squamous Cell Carcinoma

A Study of the Expressions of Survivin and Bcl-2 in Lung Squamous Cell Carcinoma with Different Radiosensitivity

Expression and Clinical Significance of Survivin and P63 Protein in Esophageal Squamous Carcinoma

Relationship Between Expression of Survivin Gene and Biological Characteristics in Human Esophageal Carcinoma

Clinical significance of carcinoembryonic antigen-, cytokeratin 19-, or survivin-positive circulating tumor cells in the peripheral blood of esophageal squamous cell carcinoma patients treated with radiotherapy

Expression and localization of survivin associates with cell proliferation, apoptosis and the prognosis significance in squamous cell carcinoma of esophagus

The expressions of survivin and nm23-h1 genes in esophageal squamous cell carcinoma and the clinical significance of the combined detection

The Expression and Correlation of ERK1/2 and Survivin in Esophageal Cancer

Relationship of Survivin to Occurrence and Prognosis of Cervical Cancer

Prognostic significance of CYFRA21-1, CEA and hemoglobin in patients with esophageal squamous cancer undergoing concurrent chemoradiotherapy.